相关实验视频
Updated: Sep 18, 2025

04:16
Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
8.9K
脊髓灰质炎后诊所患者的骨生物标志物
Seyed Pezhman Madani1, Richard Kremer2,3, Ami Grunbaum2,3,4
1Department of Neurology, Montreal Neurological Institute-Hospital, McGill University Health Centre, McGill University, Montreal, QC, Canada.
Frontiers in endocrinology
|June 23, 2025
概括
脊髓灰质炎后患有骨质疏松症的患者表现出较低的骨转化标记 (BTM) 比对照组. 双酸盐治疗在两组中都降低了BTM,这表明BTM可以监测脊髓灰质炎后骨质疏松症的治疗反应.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 神经学 神经学
背景情况:
- 骨质疏松症在脊髓灰质炎后的患者中普遍存在 (30-50%).
- 脊髓灰质炎后骨质疏松症的骨生物标志物水平和双酸盐反应尚不清楚.
研究的目的:
- 为了将脊髓灰质炎后的骨质疏松症患者的骨生物标志物水平与对照进行比较.
- 为了评估双酸盐治疗对脊髓灰质炎后患者骨生物标志物的影响,与对照对比.
主要方法:
- 脊髓灰质炎后和骨代谢诊所患者的回顾性图表审查.
- 排除没有骨质疏松症或数据不完整的患者;未接受双酸盐治疗的患者被排除在治疗分析之外.
主要成果:
- 脊髓灰质炎后的患者 (n=25) 和对照组 (n=31) 的人口结构相似.
- 在脊髓灰质炎后的患者中观察到较低的副甲状腺激素 (PTH) 和血清骨循环标记 (sBTM).
- 双酸盐治疗在两组中都减少了sBTMs,对骨素和C-telopeptide的对照减少更大.
结论:
- 脊髓灰质炎后的骨质疏松症与骨循环减少有关.
- 骨循环标志物显示出监测脊髓灰质炎后患者对双酸盐治疗反应的潜力.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
353
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
223
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
223

